|
UBE3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.65959493212154E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.0305982430009E-11 |
| Normal-vs-Stage2 |
4.064100E-03 |
| Normal-vs-Stage3 |
1.96491999999715E-05 |
| Normal-vs-Stage4 |
3.827600E-02 |
| Stage1-vs-Stage2 |
6.233000E-01 |
| Stage1-vs-Stage3 |
9.869600E-01 |
| Stage1-vs-Stage4 |
6.071200E-01 |
| Stage2-vs-Stage3 |
6.715000E-01 |
| Stage2-vs-Stage4 |
9.021200E-01 |
| Stage3-vs-Stage4 |
6.132000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55839818616732E-11 |
| Normal-vs-AfricanAmerican |
1.05139999995174E-06 |
| Normal-vs-Asian |
5.260400E-02 |
| Caucasian-vs-AfricanAmerican |
7.202200E-01 |
| Caucasian-vs-Asian |
7.145800E-01 |
| AfricanAmerican-vs-Asian |
6.248800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.54969395491389E-12 |
| Normal-vs-Female |
7.9276000000017E-05 |
| Male-vs-Female |
3.543600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.79000000000351E-05 |
| Normal-vs-Extreme_Weight |
1.08860032099756E-10 |
| Normal-vs-Obese |
1.21840000000262E-06 |
| Normal-vs-Extreme_Obese |
6.497900E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.198200E-01 |
| Normal_Weight-vs-Obese |
7.910600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.583000E-01 |
| Extreme_Weight-vs-Obese |
1.442640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.995600E-01 |
| Obese-vs-Extreme_Obese |
6.110200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.214100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.38219999954192E-07 |
| Normal-vs-Age(61-80Yrs) |
3.39872574528499E-12 |
| Normal-vs-Age(81-100Yrs) |
2.212800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.909200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.196000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.414300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.992350E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.296200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.983200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.00559577226522E-11 |
| Normal-VS-Type2 PRCC |
3.62790000041358E-07 |
| Normal-VS-KIRP CIMP |
7.80210000000947E-05 |
| Normal-VS-Unclassified PRCC |
1.144180E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.533800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.489800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.537800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.787400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.139000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.421600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.41291447828007E-12 |
| Normal-vs-N1 |
9.084800E-03 |
| Normal-vs-N2 |
2.155200E-04 |
| N0-vs-N1 |
2.954100E-02 |
| N0-vs-N2 |
9.664800E-01 |
| N1-vs-N2 |
3.770200E-01 |
|
|
